Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 18 | 0 | 1 | 0 | €98.19 | €116.48 | 18.627% |
| AbbVie Inc. | 34 | 0 | 13 | 0 | €160.50 | €175.88 | 9.584% |
| Abeona Therapeutics Inc. | 4 | 1 | 0 | 0 | €3.82 | €33.73 | 782.942% |
| AC Immune Ltd | 5 | 0 | 2 | 0 | €3.72 | €12.27 | 229.935% |
| Aclaris Therapeutics Inc | 2 | 0 | 1 | 0 | €1.04 | €2.75 | 163.410% |
| Adverum Biotechnologies Inc. | 8 | 0 | 1 | 0 | €1.38 | €13.07 | 847.449% |
| Affimed N.V. | 12 | 6 | 4 | 0 | €0.55 | €6.61 | 1095.570% |
| Agios Pharmaceuticals Inc. | 8 | 0 | 2 | 0 | €41.80 | €43.87 | 4.950% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.05 | - | - |
| Alkermes plc | 14 | 2 | 1 | 0 | €22.80 | €34.08 | 49.477% |
| Alnylam Pharmace. | 45 | 1 | 9 | 1 | €229.60 | €249.78 | 8.788% |
| Amgen Inc. | 26 | 0 | 1 | 0 | €292.90 | €300.48 | 2.588% |
| Amicus Therapeutics Inc. | 7 | 0 | 1 | 0 | €9.15 | €17.64 | 92.762% |
| AnaptysBio Inc | 8 | 1 | 0 | 0 | €22.00 | €45.21 | 105.500% |
| Anika Therapeutics | 5 | 0 | 0 | 0 | €24.00 | €28.29 | 17.878% |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €5.73 | €11.00 | 92.106% |
| arGEN X BV | 1 | 0 | 0 | 0 | €416.60 | €470.00 | 12.818% |
| Arrowhead Pharmaceuticals Inc. | 20 | 2 | 6 | 0 | €24.59 | €54.74 | 122.627% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €127.00 | €150.00 | 18.110% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €147.95 | €165.00 | 11.524% |
| Aurinia Pharmaceuticals Inc. | 1 | 1 | 1 | 0 | €5.16 | €8.75 | 69.442% |
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |